Professional Documents
Culture Documents
Page 1 of 17
www.igateresearch.com
iGATE Research
Page 2 of 17
www.igateresearch.com
The Alzheimers Disease Drugs Market has been analyzed from 7 View Points:
1. Alzheimers Disease - Drugs Sales and Forecast
2. Alzheimers Disease - Pipeline Drugs Sales Forecast
3. Alzheimers Disease Drugs - Country Wise Market and Forecast
4. Alzheimers Disease - Country Wise Prevalence and Forecast
5. Alzheimers Disease - Pipeline Drugs Clinical Trials Analysis
6. Alzheimers Disease - Major Deals in Alzheimers Drugs Market
7. Alzheimers Disease - Funding in Alzheimers Disease Research
The Top 9 Alzheimers Disease Drugs covered in the report are as follows:
1. Exelon
2. Razadyne/Reminyl
3. Memary
4. Ebixa
5. Aricept
6. Rivastach
7. Namenda
8. Nootropil
9. Namzaric
The 7 Pipeline Alzheimers Disease Drugs covered in the report are as follows:
1. Solanezumab
2. ABT-126
3. idalopirdine
4. Gantenerumab
5. Crenezumab
6. Lu AE58054
7. BIIB037
iGATE Research
Page 3 of 17
www.igateresearch.com
The 9 Countries Alzheimers Disease Drugs Market covered in the report are as follows:
1. United States
2. France
3. Germany
4. Italy
5. Spain
6. United Kingdom
7. Japan
8. China
9. India
The Alzheimers Disease Drugs Major Deals covered in the report are as follows:
1. Strategic Alliance
2. Licensing Agreement
3. Collaboration Deals
4. Mergers and Acquisitions
Source of Information
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing
distinctive data sets and research material for business reports. This report is built by using
data and information sourced from Proprietary Information Database, Primary and Secondary
Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified
professionals with deep industry experience and expertise.
iGATE Research
Page 4 of 17
www.igateresearch.com
Research Methodologies
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small
Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper,
Magazine and Journal Content, Government And NGO Statistics, white Papers, Information on
the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report,
Government Agencies, Libraries And Local Councils and a large number of Paid Databases.
iGATE Research
Page 5 of 17
www.igateresearch.com
About Us
iGATE RESEARCH is a global specialist in the field of Market Research, Analytics and
Consulting Services. We serve as a one stop shop for all the market and industry research needs
including Syndicated Research, Customized Research and Analytics Services. iGATE Research is
a gateway of information for various companies, whether it is Building a Strategy, or
Identifying Business Opportunity, Product Expansion, Market/Business Expansion, Competition
Assessment, etc. Combining deep understanding of the industry along with the expertise, we
help our clients in making better Business decisions.
At iGATE, we have a dedicated team of highly qualified and skilled professionals with deep
industry experience and expertise to manage complex report. We aim to offer high quality
Research Solutions to clients across multiple industries including Healthcare, Life Sciences,
Travel and Tourism, Retail, IT, Telecom, Consumer Retailing among others. We strive to
surpass our clients expectations with every single project report.
iGATE Research team is comprised of Professionals having degree in Engineering, Management
Professionals, Biotech and other experts from relevant fields. The extensive background of our
team enables us to advise clients on a range of business initiatives, product testing, Market
entry, business opportunity, formulate strategy, etc which helps them in making informed
Business decisions.
iGATE Research
Page 6 of 17
www.igateresearch.com
Published
By
iGATE RESEARCH
Phone: +91-858-684-0791 (India)
+91-706-527-9335 (India)
Email: info@igateresearch.com
Internet: www.igateresearch.com
Global Alzheimers Disease Drugs Market & Pipeline Drugs Market Analysis to 2020
iGATE Research Pvt. Ltd., 2015
Edition 1.0
All Rights Reserved.
No part of this Publication may be reproduced or transmitted
in any form or by any means, electronic or mechanical, including
photocopying, recording, or by any information storage
and retrieval system, without permission in
writing from the publisher.
iGATE Research
Page 7 of 17
www.igateresearch.com
Table of Contents
1.
Executive Summary
2.
2.2
3.
Global Alzheimers Disease - Country Wise Market Share and Forecast (2013 - 2020)
4.
5.
4.1
4.2
4.3
4.4
4.5
4.6
4.7
4.8
4.9
5.1.1
About Solanezumab
5.1.2
Clinical Trials
5.1.3
5.2
5.2.1
About ABT-126
5.2.2
Clinical Trials
5.2.3
5.3
5.3.1
About Idalopirdine
5.3.2
Clinical Trials
5.3.3
iGATE Research
Page 8 of 17
www.igateresearch.com
5.4
5.4.1
About Gantenerumab
5.4.2
Clinical Trials
5.4.3
5.5
5.5.1
About Crenezumab
5.5.2
Clinical Trials
5.5.3
5.6
5.6.1
About Lu AE58054
5.6.2
Clinical Trials
5.6.3
5.7
6.
5.7.1
About BIIB037
5.7.2
Clinical Trials
5.7.3
6.1.1
United States - Alzheimers Disease Drugs Market and Forecast (2013 - 2020)
6.1.2
6.2
6.2.1
6.2.2
6.3
6.3.1
6.3.2
6.4
6.4.1
6.4.2
6.5
6.5.1
6.5.2
6.6
iGATE Research
Page 9 of 17
www.igateresearch.com
6.6.1
United Kingdom - Alzheimers Disease Drugs Market and Forecast (2013 - 2020)
6.6.2
6.7
6.7.1
6.7.2
6.8
8.
9.
6.8.1
6.8.2
6.9
7.
6.9.1
6.9.2
7.2
7.3
7.4
8.2
8.3
8.4
8.5
9.1.1
9.1.2
9.1.3
Worldwide - Distribution of Population Aged 60 Years or Over By Broad Age Group, 1950 -
2050
9.2
9.3
iGATE Research
Page 10 of 17
www.igateresearch.com
9.4
10.
10.1
10.2
10.3
10.4
10.5
10.6
10.7
10.7.1
Unite States
10.7.2
France
10.7.3
Germany
10.7.4
United Kingdom
10.7.5
Japan
10.7.6
China
10.7.7
India
iGATE Research
Page 11 of 17
www.igateresearch.com
List of Figures:
Figure 2-1: Global - Alzheimers Disease Drugs Market (Million US$), 2010 - 2014
Figure 2-2: Global - Forecast for Alzheimers Disease Drugs Market (Million US$), 2015 - 2020
Figure 2-3: Global - Alzheimers Disease Prevalence (Million), 2010 - 2014
Figure 2-4: Global - Forecast for Alzheimers Disease Prevalence (Million), 2015 - 2020
Figure 4-1: Global - Exelon Drugs Sales (Million US$), 2003 - 2014
Figure 4-2: Global - Forecast for Exelon Drugs Sales (Million US$), 2015 - 2020
Figure 4-3: Global - Razadyne/Reminyl Drugs Sales (Million US$), 2010 - 2014
Figure 4-4: Global - Forecast for Razadyne/Reminyl Drugs Sales (Million US$), 2015 - 2020
Figure 4-5: Global - Memary Drugs Sales (Million US$), 2011 - 2014
Figure 4-6: Global - Forecast for Memary Drugs Sales (Million US$), 2015 - 2019
Figure 4-7: Global - Ebixa Drugs Sales (Million US$), 2003 - 2014
Figure 4-8: Global - Forecast for Ebixa Drugs Sales (Million US$), 2015 - 2020
Figure 4-9: Global - Aricept Drugs Sales (Million US$), 2009 - 2014
Figure 4-10: Global - Forecast for Aricept Drugs Sales (Million US$), 2015 - 2019
Figure 4-11: Global - Rivastach Drugs Sales (Million US$), 2011 - 2014
Figure 4-12: Global - Forecast for Rivastach Drugs Sales (Million US$), 2015 - 2020
Figure 4-13: Global - Namenda Drugs Sales (Million US$), 2003 - 2014
Figure 4-14: Global - Forecast for Namenda Drugs Sales (Million US$), 2015 - 2020
Figure 4-15: Global - Nootropil Drugs Sales (Million US$), 2004 - 2014
Figure 4-16: Global - Forecast for Nootropil Drugs Sales (Million US$), 2015 - 2020
Figure 4-17: Global - Forecast for Namzaric Drugs Sales (Million US$), 2015 - 2020
Figure 5-1: Global - Forecast for Solanezumab Drugs Sales (Million US$), 2017 - 2020
Figure 5-2: Global - Forecast for ABT-126 Drugs Sales (Million US$), 2017 - 2020
Figure 5-3: Global - Forecast for Idalopirdine Drugs Sales (Million US$), 2017 - 2020
Figure 5-4: Global - Forecast for Gantenerumab Drugs Sales (Million US$), 2017 - 2020
Figure 5-5: Global - Forecast for Crenezumab Drugs Sales (Million US$), 2018 - 2020
Figure 5-6: Global - Forecast for Lu AE58054 Drugs Sales (Million US$), 2017 - 2019
Figure 5-7: Global - Forecast for BIIB037 Drugs Sales (Million US$), 2019 - 2020
Figure 6-1: United States - Alzheimers Disease Drugs Market (Million US$), 2013 - 2014
Figure 6-2: United States - Forecast for Alzheimers Disease Drugs Market (Million US$), 2015 - 2020
Figure 6-3: United States - Alzheimers Disease Prevalence (Thousand), 2012 - 2014
Figure 6-4: United States - Forecast for Alzheimers Disease Prevalence (Thousand), 2015 - 2020
Figure 6-5: France - Alzheimers Disease Drugs Market (Million US$), 2013 - 2014
Figure 6-6: France - Forecast for Alzheimers Disease Drugs Market (Million US$), 2015 - 2020
iGATE Research
Page 12 of 17
www.igateresearch.com
iGATE Research
Page 13 of 17
www.igateresearch.com
Figure 8-5: Alzheimers Drug Discovery Foundation - Alzheimers Disease Research Funding (Million US$),
2008 - 2013
Figure 9-1: Worldwide - Population Aged 60 or Over: World and Development Regions, 1950, 1975, 2009,
2025 & 2050
Figure 9-2: Worldwide - Old-Age Dependency Ratio: Major Areas, 2009 & 2050
Figure 9-3: Worldwide - Distribution of population aged 60 years or over by broad age group, 1950 - 2050
Figure 9-4: Global - Forecast for Alzheimers Disease Pipeline Drugs Market (Million US$), 2017 - 2020
Figure 10-1: Unsuccessful Alzheimers Drug Development (Number), 1998 - 2011
iGATE Research
Page 14 of 17
www.igateresearch.com
List of Tables:
Table 3-1: Country Wise - Alzheimers Disease Drugs Market Share (Percent), 2013 - 2014
Table 3-2: Country Wise - Forecast for Alzheimers Disease Drugs Market Share (Percent), 2015 - 2020
Table 7-1: Global Alzheimers Disease Drugs Market - Strategic Alliance, 2003 - 2015
Table 7-2: Global Alzheimers Disease Drugs Market - Licensing Agreement, 2007 - 2015
Table 7-3: Global Alzheimers Disease Drugs Market - Collaboration Deals, 2005 - 2015
Table 7-4: Global Alzheimers Disease Drugs Market - Mergers and Acquisitions, 2008 - 2015
Table 8-1: BrightFocus Foundation - Alzheimers Disease Research Funding (Million US$), 2010 - 2014
Table 9-1: Global - Ageing Indicators (Percent), 2011/2012 - 2050
Table 9-2: Global - Population (Number), 2011/2012 - 2050
Table 9-3: Ten Countries or Areas with the Aging Populations 1950,1980,2013,2050 & 2100(Medium
Variant)
iGATE Research
Page 15 of 17
www.igateresearch.com
US$ 1,100
US$ 1,250
US$ 1,200
US$ 1,600
iGATE Research
Page 16 of 17
www.igateresearch.com
Contact US
iGATE RESEARCH PVT. LTD.
Web: www.igateresearch.com
To order the Report:
E-Mail: info@igateresearch.com
Contact No. : +91-858-684-0791, +91-706-527-9335/9336 (INDIA)
For Report Related Query:
E-Mail: ravi.sinha@igateresearch.com
Contact No. : +91-858-684-0791, +91-706-527-9335 (INDIA)
Follow US
Facebook: https://www.facebook.com/pages/IGATE-Research/1569079456648005?sk=timeline
Twitter: https://twitter.com/IgateResearch
You Tube: https://www.youtube.com/channel/UCOr7KNn4JfTwk5_kQjj-xrQ
Google+: https://plus.google.com/110560526954506242845/posts
Linkedin:https://www.linkedin.com/profile/view?authType=NAME_SEARCH&locale=en_US&id=
374611590&trk=tyah&trkInfo=tarId%3A1414504898315%2Ctas%3Aigate+research%2Cidx%3A1-11&authToken=YgR7
iGATE Research
Page 17 of 17
www.igateresearch.com